Topic: T Cell Expansion: Complete Workflow Solutions in Dynamic Cultivation Conditions
Presenter: Deborah LD. Maybruch, PhD, Field Application Scientist - Life Science Business Unit, FUJIFILM Irvine Scientific

In recent years, there has been a significant increase in development of T cell therapies, which have the potential to transform the treatment of a number of diseases, including cancer, genetic conditions, degenerative diseases, and even severe injuries. However, generating sufficient cell numbers with consistent clinical quality can be a major challenge for cell and gene therapy developers. Therefore, reducing variability and risk is imperative for reliable and efficient therapy production. By maintaining a chemically defined and animal component-free environment, developers are able to achieve consistent activation and expansion of T cells.

Discover the benefits of using chemically defined media and recombinant human proteins to reliably culture, differentiate, and expand T cells. Watch this presentation to learn more about the:

• Key considerations when selecting raw materials for cell culture media development
• The potential of chemically defined and serum-free cell culture media for T cell expansion
• Developing recombinant growth factors and cytokines for cell-based therapies
• Supplementing cell and tissue culture media in chemically defined settings
• T cell expansion in static and dynamic culture conditions